End in sight for GHTF; new regulators-only forum on horizon
This article was originally published in Clinica
The founding members of the Global Harmonization Task Force have agreed to terminate the body and are proposing to replace it with a regulators-only forum in the future. The GHTF for the past 18 years or so has been working towards developing a regulatory model and supporting documents to underpin globally harmonised regulation of medical devices.
You may also be interested in...
In the first of a two-part article on transparency provisions for the new EU clinical trial portal, the Pink Sheet reports on aspects that sponsors must consider to protect commercially confidential information in their clinical trial applications. The second article will look at the approach taken by Merck and discuss outstanding hot topics in relation to transparency and CTIS.
An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.
EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.